Latest Regulation News

Range International Limited reported a robust Q2 2025 with revenue surging 75% year-over-year and strong operational momentum despite supply challenges. The company’s strategic moves in Indonesia and the Philippines, alongside a favorable tax court ruling, set the stage for an ambitious growth trajectory.

Rand Mining Ltd reports a solid increase in the East Kundana Joint Venture’s mineral resources and ore reserves for 2024, reflecting updated gold price assumptions and operational cost reviews.

DataWorks Group reports a dramatic reduction in cash outflows and rising revenues, driven by strong contract execution and cost discipline, setting the stage for positive operating cash flow by December 2025.

Caravel Minerals has secured a $15 million non-dilutive loan facility to fund the Definitive Feasibility Study for its Caravel Copper Project, alongside finalising a simplified process flowsheet and initiating key engineering tenders.

Jameson Resources has significantly boosted the economic outlook of its Crown Mountain Hard Coking Coal Project, doubling its pre-tax NPV to US$942 million, while advancing environmental approvals and Indigenous partnerships in British Columbia.

The Takeovers Panel has declined to find unacceptable circumstances in two recent applications concerning Yowie Group's share placement and related fund unit issues, providing clarity on governance and control matters.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

AdNeo Limited reports sustained positive cash flow and strong contract wins, advancing its strategic acquisition of Learnt Global ahead of schedule while securing $5.5 million in new capital.

The Star Entertainment Group reported steady Q4 FY25 revenue of $270 million but widened its EBITDA loss to $27 million, reflecting ongoing regulatory pressures and operational challenges. The company secured $233 million from strategic investors Bally’s Corporation and Investment Holdings, while negotiations continue over its Brisbane joint venture exit.

Actinogen Medical has reached a key milestone in its XanaMIA phase 2b/3 Alzheimer’s trial with over 100 participants enrolled, setting the stage for an interim analysis in January 2026. The company also secured a $13.8 million non-dilutive R&D funding facility to support ongoing development.

Capricorn Metals reported a strong June quarter with Karlawinda gold production meeting FY25 guidance and announced it is now debt free and unhedged. Development at Mt Gibson and Karlawinda Expansion projects progresses, supported by record cash flow.

Nexus Minerals has reported a significant new gold discovery at its Wallbrook Gold Project, highlighted by strong drilling results at the Payns Prospect, while progressing permitting for the Crusader-Templar deposit and maintaining a solid cash position.